Skip to content

Antioxidant status following postprandial challenge of two different doses of tocopherols and tocotrienols

The postprandial antioxidant potential of vitamin E (alpha-tocopherol and tocotrienols) in humans

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001251213
Enrollment
10
Registered
2018-07-25
Start date
2003-03-17
Completion date
2003-06-16
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Dietary intake of tocotrienols (T3) were postulated to have a measurable effect on their antioxidant effectiveness It appears that the amount of T3 ingested may not have an impact on plasma antioxidant status. In the current study, the T3 antioxidant effectiveness is believed to be limited by their low uptake or bioavailability in humans. Therefore, we compared the antioxidant effectiveness following postprandial challenge of a-tocopherol or palm T3-rich fraction (TRF) supplementations. We also investigated whether there is a dose-response effect on plasma antioxidant status following various doses of either a-tocopherol or TRF treatments. The dose response effect of plasma antioxidant status was determined from the differences in the total plasma antioxidant status at each postprandial interval (2 h, 4 h, 5 h, 6 h and 8 h).

Interventions

Volunteers were conditioned on a standardized fat-controlled diet (comprising breakfast, lunch and afternoon high tea) for seven days prior to each postprandial intervention during which a-Tocopherol and palm tocotrienol rich-fraction (TRF) supplements at specific doses were administered separately. A one week wash-out period was allowed between each rotation. Corn oil was used as the dietary fat source for meals preparations, and the same menu was repeated for each rotation. Daily food samples

Volunteers were conditioned on a standardized fat-controlled diet (comprising breakfast, lunch and afternoon high tea) for seven days prior to each postprandial intervention during which a-Tocopherol and palm tocotrienol rich-fraction (TRF) supplements at specific doses were administered separately. A one week wash-out period was allowed between each rotation. Corn oil was used as the dietary fat source for meals preparations, and the same menu was repeated for each rotation. Daily food samples were duplicated and analyzed for fat and vitamin E content as well as composition. Clarification: Volunteers were provided up to THREE (3) different meals in the fat-controlled diet, per day. The meals were prepared by the trained caterer. The "Fat-controlled" diet in this study refers to the daily every daily meal provided to volunteers who were recruited into the trial. The meals were prepared by a trained caterer where menus and cooking guidelines were provided by the Investigators. Analysis of fat content on trial samples of the meals were used in drawing up the menu. The most critical part was that, the fat content should provided about 30% of total energy needs and the daily meals should be balanced, containing macronutrients and micronutrients from all of the food groups in the appropriated proportion promoting good health. Supplementation of vitamin E treatments comprising 268 mg a-Tocopherol, 537 mg a-Tocopherol, 263 mg palm T3 rich-fraction (TRF) or 526 mg TRF. Each volunteers consumed a single acute dose in the morning. Vitamin E supplement was in form of oral tablet. For monitoring compliance, each volunteers consumed the supplementation in front of the Investigator during the postprandial challenge.

Sponsors

Malaysian Palm Oil Board (MPOB)
Lead SponsorGovernment body

Study design

Allocation
Non-randomised trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
19 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

All volunteers were healthy, normolipemic, nonsmokers, did not show any clinical symptoms associated with lipid-related cardiovascular disease and none of them consumed any supplements or on medication. For females, they were not pregnant, lactating, or taking contraceptives at the time of enrollment.

Exclusion criteria

Smoking, show any clinical symptoms associated with lipid-related cardiovascular disease, consumed any supplements or on medication. For females, pregnant, lactating, or taking contraceptives at the time of enrollment.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026